scholarly journals One Profession-but not one Oath; a new survey revisiting the Chiropractic Oaths

2020 ◽  
pp. 427-444
Author(s):  
Marshall N. Deltoff

Thirty years ago, in 1988, we undertook the first formal academic examination of the Chiropractic Oath: its development and an analysis of its component parts. At that time, we studied 38 oaths from 25 different chiropractic colleges. Various themes and topics were identified, some of which occurred consistently, and others appearing but once or twice. With the recent global expansion of our profession to new schools in many more countries, the oaths presently used at chiropractic colleges worldwide were subjected to the same analysis for comparison. 42 oaths were obtained from the 45 institutions currently listed on the World Federation of Chiropractic website.    Increased access, both electronically and in person, has enabled our academic institutions to communicate and relate at a level unimaginable thirty years ago. This increasing college interaction is one aspect of our progressive unity. It is proposed that consideration be given to the development of a single Chiropractic Oath as a tangible example of this professional unity.

Vox Sanguinis ◽  
1991 ◽  
Vol 61 (3) ◽  
pp. 221-224
Author(s):  
C.K. Kasper ◽  
P.M. Mannucci ◽  
V. Bulyzhenkov ◽  
D.B. Brettler ◽  
A. Chuansumrit ◽  
...  

2021 ◽  
pp. 135245852110302
Author(s):  
Joanna Laurson-Doube ◽  
Nick Rijke ◽  
Anne Helme ◽  
Peer Baneke ◽  
Brenda Banwell ◽  
...  

Background: Off-label disease-modifying therapies (DMTs) for multiple sclerosis (MS) are used in at least 89 countries. There is a need for structured and transparent evidence-based guidelines to support clinical decision-making, pharmaceutical policies and reimbursement decisions for off-label DMTs. Objectives/Results: The authors put forward general principles for the ethical use of off-label DMTs for treating MS and a process to assess existing evidence and develop recommendations for their use. Conclusion: The principles and process are endorsed by the World Federation of Neurology (WFN), American Academy of Neurology (AAN), European Academy of Neurology (EAN), Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Middle-East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) and Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS), and we have regularly consulted with the Brain Health Unit, Mental Health and Substance Use Department at the World Health Organization (WHO).


2009 ◽  
Vol 33 (1) ◽  
pp. 68-78
Author(s):  
Will Longstreth ◽  
Than Ton ◽  
Amethyst Leimpeter ◽  
Stephen K. Van Den Eeden

Nature ◽  
1964 ◽  
Vol 204 (4955) ◽  
pp. 233-233
Keyword(s):  

1985 ◽  
Vol 23 (3) ◽  
pp. 330-332
Author(s):  
Willem Luyendijk ◽  
H.Alphons D. Walder
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document